Astrocyte Pharmaceuticals Awarded $3M NIH Small Business Grant to Advance TBI and Concussion Therapeutic

19Sep

Cambridge, MA, September 19, 2018 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that it has been awarded a $3 million Phase 2 Small Business Innovation Research...

Posted by korinek
in Press Releases

Astrocyte Pharmaceuticals Awarded Alzheimer’s Disease Research Grant

18Sep

Cambridge, MA, September 18, 2018 – Astrocyte Pharmaceuticals, Inc., a privately held pharmaceutical company, announced today that it has been awarded $287k Phase 1 Small Business Technology Transfer...

Posted by korinek
in Press Releases

Astrocyte Pharmaceuticals Completes $2.4M Seed Financing Round

17Jul

Cambridge, MA, July 17, 2017 – Astrocyte Pharmaceuticals Inc. announced today that it has completed its seed financing round raising over $2.4M. The company is developing novel small molecule drugs...

Posted by korinek
in Press Releases

Astrocyte Pharmaceuticals Raises Over $1.3M in Seed Financing Round

24Mar

Cambridge, MA, March 24, 2017 – Astrocyte Pharmaceuticals Inc., a CNS therapeutics startup, announced today that it has raised approximately $1.36M in a seed financing round. The company is developing...

Posted by korinek
in Press Releases

Former Army TBI Research Leader Col. Dallas Hack Joins Astrocyte Pharmaceuticals’ Scientific Advisory Board

19Dec

Cambridge, MA, December 19, 2016 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Colonel (retired) Dallas C. Hack, MD, MPH has joined the company’s Scientific...

Posted by korinek
in Press Releases

Leading Emergency Clinician David W. Wright Joins Astrocyte Pharmaceuticals’ Scientific Advisory Board

19Oct

Cambridge, MA, October 19, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that David W. Wright, M.D., has joined the company’s Scientific Advisory Board....

Posted by korinek
in Press Releases

Astrocyte Pharmaceuticals Awarded NIH Small Business Grant to Advance TBI and Concussion Therapeutic

21Sep

Cambridge, MA, September 21, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that it has been awarded a Phase 1 Small Business Technology Transfer (STTR)...

Posted by korinek
in Press Releases

Dr. Susan S. Margulies Joins Astrocyte Pharmaceuticals’ Scientific Advisory Board

16Jul

Cambridge, MA, July 16, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Susan S. Margulies, Ph.D. has joined the company’s Scientific Advisory Board....

Posted by korinek
in Press Releases

Licensing Agreement Advances Preclinical Therapy for Brain Injuries, Including Concussion

7May

Cambridge, Mass. (May 7, 2015) – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, today announced it has entered into an exclusive worldwide licensing agreement with The University...

Posted by korinek
in Press Releases

Dr. Theodore Liston to Lead Pharmacokinetics and Pharmacodynamics at Astrocyte Pharmaceuticals

1May

Cambridge, Mass., May 1, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Theodore E. Liston, Ph.D. has joined the company as Vice President of Pharmacokinetics...

Posted by korinek
in Press Releases

Category: Press Releases